Myasthenia gravis

Nov 07, 2019

Global Generalized Myasthenia Gravis (gMG) Epidemiology Report 2019: Population of Seven Major Markets was Found to be 58,828 in 2017 - Forecast to 2028

Nov 05, 2019

Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis

Nov 04, 2019

Myasthenia Gravis: Epidemiology Forecast to 2028

Sep 24, 2019

GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to DAS Therapeutics

Jan 18, 2019

Global Myasthenia Gravis Market 2017-2018 & 2026: Increase in Occurrence of Autoimmune Disorders and Strong Pipeline Propelling Market Growth

Oct 18, 2018

UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis Into Confirmatory Development Phase

Mar 26, 2018

GT Biopharma, Inc. Announces Additional Positive Data From Its Phase 1 Clinical Trial For Myasthenia Gravis and Potential for Acceleration of the Start of Its Phase 2 Trial

Jan 09, 2018

GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004 for Myasthenia Gravis

Dec 05, 2017

Myasthenia Gravis Market Value to Reach US$2,313.1 Million by the End of 2025: Transparency Market Research

Aug 08, 2017

Myasthenia Gravis Market Analysis: Global Size, Share, Trends, Growth Drivers, Industry Demand, Competitive Landscape and Forecasts to 2021- MarketReportsOnline